Immunological aspects of Candida and Aspergillus systemic fungal infections

Interdisciplinary Perspectives on Infectious Diseases

Volumn 2013, Issue , 2013, Pages

  Mueller Loebnitz, Christoph ^a   Ostermann, Helmut ^b   Franzke, Anke ^c   Loeffler, Juergen ^d   Uharek, Lutz ^e   Topp, Max ^d   Einsele, Hermann ^d  

^a Medical Writer   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c LEIBNIZ UNIVERSITY HANNOVER   (Germany)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; DECTIN 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 23; MYELOID DIFFERENTIATION FACTOR 88; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; AIR FILTER; AIR POLLUTION; ANTIBIOTIC THERAPY; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CELLULAR IMMUNITY; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONIDIUM; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE ASSOCIATION; EFFECTOR CELL; FUNGAL CONTAMINATION; FUNGAL DETECTION; FUNGUS IMMUNITY; GENE MUTATION; GENETIC RISK; HAPLOTYPE; HEMATOLOGIC MALIGNANCY; HIGH EFFICIENCY PARTICULATE AIR FILTER; HIGH RISK PATIENT; HUMAN; IMMUNOTHERAPY; INNATE IMMUNITY; INTENSIVE CARE; INVASIVE ASPERGILLOSIS; INVASIVE CANDIDIASIS; LAMINAR AIRFLOW; LOSS OF FUNCTION MUTATION; MACROPHAGE; META ANALYSIS; MONOCYTE; NATURAL KILLER CELL; NEUTROPENIA; NEUTROPHIL; NONHUMAN; ORGAN TRANSPLANTATION; PATHOGEN CLEARANCE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATIC DISEASE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC DISEASE; SYSTEMIC MYCOSIS; TH17 CELL;

EID: 84874615319     PISSN: 1687708X     EISSN: 16877098     Source Type: Journal    
DOI: 10.1155/2013/102934     Document Type: Review

References (44)

1. de Pauw B., Walsh T. J., Donnelly J. P., Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC/MSG) consensus group. Clinical Infectious Diseases 2008 46 12 1813 1821 10.1086/588660
2. Engel C., Brunkhorst F. M., Bone H. G., Brunkhorst R., Gerlach H., Grond S., Gruendling M., Huhle G., Jaschinski U., John S., Mayer K., Oppert M., Olthoff D., Quintel M., Ragaller M., Rossaint R., Stuber F., Weiler N., Welte T., Bogatsch H., Hartog C., Loeffler M., Reinhart K., Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Medicine 2007 33 4 606 618 2-s2.0-33947518492 10.1007/s00134-006-0517-7 (Pubitemid 46474888)
3. Cornillet A., Camus C., Nimubona S., Gandemer V., Tattevin P., Belleguic C., Chevrier S., Meunier C., Lebert C., Aupée M., Caulet-Maugendre S., Faucheux M., Lelong B., Leray E., Guiguen C., Gangneux J. P., Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. Clinical Infectious Diseases 2006 43 5 577 584 2-s2.0-33747616462 10.1086/505870 (Pubitemid 44267116)
4. Meersseman W., Vandecasteele S. J., Wilmer A., Verbeken E., Peetermans W. E., van Wijngaerdert E., Invasive aspergillosis in critically ill patients without malignancy. American Journal of Respiratory and Critical Care Medicine 2004 170 6 621 625 2-s2.0-4444302605 10.1164/rccm.200401-093OC (Pubitemid 39202203)
5. Portugal R. D., Garnica M., Nucci M., Index to predict invasive mold infection in high-risk neutropenic patients based on the area over the neutrophil curve. Journal of Clinical Oncology 2009 27 23 3849 3854 2-s2.0-68949108384 10.1200/JCO.2008.21.0856
6. Rupp M. E., Iwen P. C., Tyner L. K., Marion N., Reed E., Anderson J. R., Routine sampling of air for fungi does not predict risk of invasive aspergillosis in immunocompromised patients. Journal of Hospital Infection 2008 68 3 270 271 2-s2.0-40649098205 10.1016/j.jhin.2007.11.017
7. Eckmanns T., Rüden H., Gastmeier P., The influence of high-efficiency particulate air filtration on mortally and fungal infection among highly immunosuppressed patients: a systematic review. Journal of Infectious Diseases 2006 193 10 1408 1418 2-s2.0-33646354627 10.1086/503435 (Pubitemid 43673389)
8. Maschmeyer G., Neuburger S., Fritz L., Böhme A., Penack O., Schwerdtfeger R., Buchheidt D., Ludwig W. D., A prospective, randomised study on the use of well-fitting masks for prevention of invasive aspergillosis in high-risk patients. Annals of Oncology 2009 20 9 1560 1564 2-s2.0-69949090024 10.1093/annonc/mdp034
9. Araujo R., Carneiro A., Costa-Oliveira S., Pina-Vaz C., Rodrigues A. G., Guimaraes J. E., Fungal infections after haematology unit renovation: evidence of clinical, environmental and economical impact. European Journal of Haematology 2008 80 5 436 443 2-s2.0-41849091492 10.1111/j.1600-0609.2008.01034. x (Pubitemid 351503101)
10. Nivoix Y., Velten M., Letscher-Bru V., Moghaddam A., Natarajan-Amé S., Fohrer C., Lioure B., Bilger K., Lutun P., Marcellin L., Launoy A., Freys G., Bergerat J. P., Herbrecht R., Factors associated with overall and attributable mortality in invasive aspergillosis. Clinical Infectious Diseases 2008 47 9 1176 1184 2-s2.0-53349171951 10.1086/592255
11. Bochud P. Y., Chien J. W., Marr K. A., Leisenring W. M., Upton A., Janer M., Rodrigues S. D., Li S., Hansen J. A., Lue P. Z., Aderem A., Boeckh M., Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. The New England Journal of Medicine 2008 359 17 1766 1777 2-s2.0-54949144335 10.1056/NEJMoa0802629
12. Kesh S., Mensah N. Y., Peterlongo P., Jaffe D., Hsu K., van den Brink M., O'reilly R., Pamer E., Satagopan J., Papanicolaou G. A., TLR1 and TLR6 polymorphisms are associated with susceptibility to invasive aspergillosis after allogeneic stem cell transplantation. Annals of the New York Academy of Sciences 2005 1062 95 103 2-s2.0-33745492610 10.1196/annals.1358.012
13. Glocker E. O., Hennigs A., Nabavi M., Schäffer A. A., Woellner C., Salzer U., Pfeifer D., Veelken H., Warnatz K., Tahami F., Jamal S., Manguiat A., Rezaei N., Amirzargar A. A., Plebani A., Hannesschläger N., Gross O., Ruland J., Grimbacher B., A homozygous CARD9 mutation in a family with susceptibility to fungal infections. The New England Journal of Medicine 2009 361 18 1727 1735 2-s2.0-70350545720 10.1056/NEJMoa0810719
14. Seo K. W., Kim D. H., Sohn S. K., Lee N. Y., Chang H. H., Kim S. W., Jeon S. B., Baek J. H., Kim J. G., Suh J. S., Lee K. B., Protective role of interleukin-10 promoter gene polymorphism in the pathogenesis of invasive pulmonary aspergillosis after allogeneic stem cell transplantation. Bone Marrow Transplantation 2005 36 12 1089 1095 2-s2.0-30544450276 10.1038/sj.bmt.1705181 (Pubitemid 43078138)
15. Roilides E., Dimitriadou A., Kadiltsoglou I., Sein T., Karpouzas J., Pizzo P. A., Walsh T. J., IL-10 Exerts suppressive and enhancing effects on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. The Journal of Immunology 1997 158 1 322 329 2-s2.0-0030639089 (Pubitemid 127483872)
16. Roilides E., Sein T., Roden M., Schaufele R. L., Walsh T. J., Elevated serum concentrations of interleukin-10 in nonneutropenic patients with invasive aspergillosis. Journal of Infectious Diseases 2001 183 3 518 520 2-s2.0-0035253289 10.1086/318077 (Pubitemid 32105614)
17. + regulatory T cells are essential components of the memory-protective immunity to Candida albicans. The Journal of Immunology 2002 169 11 6298 6308 2-s2.0-0036884607 (Pubitemid 36903477)
18. Wozniok I., Hornbach A., Schmitt C., Frosch M., Einsele H., Hube B., Löffler J., Kurzai O., Induction of ERK-kinase signalling triggers morphotype-specific killing of Candida albicans filaments by human neutrophils. Cellular Microbiology 2008 10 3 807 820 2-s2.0-38849195436 10.1111/j.1462-5822. 2007.01086.x (Pubitemid 351194104)
19. Nathan C., Neutrophils and immunity: challenges and opportunities. Nature Reviews Immunology 2006 6 3 173 182 2-s2.0-33344468233 10.1038/nri1785 (Pubitemid 43290987)
20. Lessing F., Kniemeyer O., Wozniok I., Loeffler J., Kurzai O., Haertl A., Brakhage A. A., The Aspergillus fumigatus transcriptional regulator AfYap1 represents the major regulator for defense against reactive oxygen intermediates but is dispensable for pathogenicity in an intranasal mouse infection model. Eukaryotic Cell 2007 6 12 2290 2302 2-s2.0-37549013791 10.1128/EC.00267-07
21. Urban C. F., Lourido S., Zychlinsky A., How do microbes evade neutrophil killing? Cellular Microbiology 2006 8 11 1687 1696 2-s2.0-33749559414 10.1111/j.1462-5822.2006.00792.x (Pubitemid 44530662)
22. Bianchi M., Hakkim A., Brinkmann V., Siler U., Seger R. A., Zychlinsky A., Reichenbach J., Restoration of NET formation by gene therapy in CGD controls aspergillosis. Blood 2009 114 13 2619 2622 2-s2.0-70350004580 10.1182/blood-2009-05-221606
23. Losse J., Zipfel P. F., Józsi M., Factor H and factor H-related protein 1 bind to human neutrophils via complement receptor 3, mediate attachment to Candida albicans, and enhance neutrophil antimicrobial activity. The Journal of Immunology 2010 184 2 912 921 2-s2.0-76249101650 10.4049/jimmunol.0901702
24. Weindl G., Naglik J. R., Kaesler S., Biedermann T., Hube B., Korting H. C., Schaller M., Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling. Journal of Clinical Investigation 2007 117 12 3664 3672 2-s2.0-36849088141 10.1172/JCI28115 (Pubitemid 350224078)
25. Aimanianda V., Bayry J., Bozza S., Kniemeyer O., Perruccio K., Elluru S. R., Clavaud C., Paris S., Brakhage A. A., Kaveri S. V., Romani L., Latgé J. P., Surface hydrophobin prevents immune recognition of airborne fungal spores. Nature 2009 460 7259 1117 1121 2-s2.0-69349091586 10.1038/nature08264
26. Schaffner A., Douglas H., Braude A. I., Davis C. E., Killing of Aspergillus spores depends on the anatomical source of the macrophage. Infection and Immunity 1983 42 3 1109 1115 2-s2.0-0021060056 (Pubitemid 14244384)
27. Philippe B., Ibrahim-Granet O., Prévost M. C., Gougerot-Pocidalo M. A., Perez M. S., Van der Meeren A., Latgé J. P., Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates. Infection and Immunity 2003 71 6 3034 3042 2-s2.0-0037900003 10.1128/IAI.71.6.3034-3042.2003 (Pubitemid 36637524)
28. Brummer E., Maqbool A., Stevens D. A., In vivo GM-CSF prevents dexamethasone suppression of killing of Aspergillus fumigatus conidia by bronchoalveolar macrophages. Journal of Leukocyte Biology 2001 70 6 868 872 2-s2.0-0035217135 (Pubitemid 33151125)
29. Loeffler J., Haddad Z., Bonin M., Romeike N., Mezger M., Schumacher U., Kapp M., Gebhardt F., Grigoleit G. U., Stevanović S., Einsele H., Hebart H., Interaction analyses of human monocytes co-cultured with different forms of Aspergillus fumigatus. Journal of Medical Microbiology 2009 58 1 49 58 2-s2.0-58149485457 10.1099/jmm.0.003293-0
30. Roilides E., Holmes A., Blake C., Venzon D., Pizzo P. A., Walsh T. J., Antifungal activity of elutriated human monocytes against Aspergillus fumigatus hyphae: enhancement by granulocyte-macrophage colony-stimulating factor and interferon- γ Journal of Infectious Diseases 1994 170 4 894 899 2-s2.0-0027981993 (Pubitemid 24296569)
31. Vora S., Chauhan S., Brummer E., Stevens D. A., Activity of voriconazole combined with neutrophils or monocytes against Aspergillus fumigatus: effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. Antimicrobial Agents and Chemotherapy 1998 42 9 2299 2303 2-s2.0-0031713711 (Pubitemid 28420368)
32. Bozza S., Gaziano R., Spreca A., Bacci A., Montagnoli C., Di Francesco P., Romani L., Dendritic cells transport conidia and hyphae of Aspergillus fumigatus from the airways to the draining lymph nodes and initiate disparate Th responses to the fungus. The Journal of Immunology 2002 168 3 1362 1371 2-s2.0-0036467527 (Pubitemid 34094507)
33. Mezger M., Kneitz S., Wozniok I., Kurzai O., Einsele H., Loeffler J., Proinflammatory response of immature human dendritic cells is mediated by dectin-1 after exposure to Aspergillus fumigatus germ tubes. Journal of Infectious Diseases 2008 197 6 924 931 2-s2.0-40949109798 10.1086/528694 (Pubitemid 351417017)
34. Perruccio K., Tosti A., Burchielli E., Topini F., Ruggeri L., Carotti A., Capanni M., Urbani E., Mancusi A., Aversa F., Martelli M. F., Romani L., Velardi A., Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. Blood 2005 106 13 4397 4406 2-s2.0-28844459420 10.1182/blood-2005-05-1775 (Pubitemid 41775954)
35. Beck O., Topp M. S., Koehl U., Roilides E., Simitsopoulou M., Hanisch M., Sarfati J., Latgé J. P., Klingebiel T., Einsele H., Lehrnbecher T., Generation of highly purified and functionally active human TH1 cells against Aspergillus fumigatus. Blood 2006 107 6 2562 2569 2-s2.0-33644778645 10.1182/blood-2005-04-1660 (Pubitemid 43345583)
36. Topp M., Personal communication. Wuerzburg, 2010
37. Bozza S., Gaziano R., Lipford G. B., Montagnoli C., Bacci A., Di Francesco P., Kurup V. P., Wagner H., Romani L., Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants. Microbes and Infection 2002 4 13 1281 1290 2-s2.0-0036848617 10.1016/S1286-4579(02)00007-2 (Pubitemid 35356454)
38. Ramadan G., Davies B., Kurup V. P., Keever-Taylor C. A., Generation of Th1 T cell responses directed to a HLA class II restricted epitope from the Aspergillus f16 allergen. Clinical and Experimental Immunology 2005 139 2 257 267 2-s2.0-13544269242 10.1111/j.1365-2249.2005.02699.x (Pubitemid 40222843)
39. Kurup V. P., Xia J. Q., Crameri R., Rickaby D. A., Choi H. Y., Flückiger S., Blaser K., Dawson C. A., Kelly K. J., Purified recombinant A. fumigatus allergens induce different responses in mice. Clinical Immunology 2001 98 3 327 336 2-s2.0-0035097281 10.1006/clim.2000.4993 (Pubitemid 32205297)
40. Chauhan B., Knutsen A. P., Hutcheson P. S., Slavin R. G., Bellone C. J., T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis. Journal of Clinical Investigation 1996 97 10 2324 2331 2-s2.0-0029997768 (Pubitemid 26165722)
41. Ruggeri L., Capanni M., Mancusi A., Martelli M. F., Velardi A., The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantation. Transplant Immunology 2005 14 3-4 203 206 2-s2.0-20544470873 10.1016/j.trim.2005.03.008 (Pubitemid 40848526)
42. Asai O., Longo D. L., Tian Z. G., Hornung R. L., Taub D. D., Ruscetti F. W., Murphy W. J., Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. Journal of Clinical Investigation 1998 101 9 1835 1842 2-s2.0-0032080398 (Pubitemid 28226101)
43. Uharek L., Personal communication. Wuerzburg, 2010
44. Park S. J., Hughes M. A., Burdick M., Strieter R. M., Mehrad B., Early NK cell-derived IFN- γ is essential to host defense in neutropenic invasive aspergillosis. The Journal of Immunology 2009 182 7 4306 4312 2-s2.0-64249134349 10.4049/jimmunol.0803462